{
    "clinical_study": {
        "@rank": "95733", 
        "acronym": "NOAHS", 
        "arm_group": {
            "arm_group_label": "No treatment."
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to examine if blood flow in the brain before coronary artery\n      bypass graft surgery has an effect on depression after surgery.\n\n      The main hypothesis of the study states that pre-surgical blood flow in the brain will be an\n      independent risk factor for depression after surgery after adjusting for other risk factors\n      such as gender, pre-CABG depression, social support, medical comorbidity burden,\n      socioeconomic status, and neuroticism."
        }, 
        "brief_title": "Intracranial Atherosclerosis and Depression After Coronary Artery Bypass Graft", 
        "condition": [
            "Depression", 
            "Intracranial Atherosclerosis", 
            "Coronary Artery Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Coronary Artery Disease", 
                "Myocardial Ischemia", 
                "Coronary Disease", 
                "Depression", 
                "Depressive Disorder", 
                "Intracranial Arteriosclerosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 40 years or older\n\n          -  Will be having CABG surgery at the Yale New Haven Hospital\n\n          -  Be able to provide informed consent\n\n          -  Have a household telephone\n\n          -  A fluent English speaker, and possessing no communication barrier\n\n          -  Be able to come to the study site or to have the study team come to his/her home.\n\n          -  Has a family member or partner/ friend who could provide collateral information\n\n        Exclusion Criteria:\n\n          -  Has had previous CABG surgery\n\n          -  History of dementia diagnosis or cognitive impairment (CDR >/= 1)\n\n          -  Auditory or visual impairment that would interfere with study procedures\n\n          -  Active alcohol or substance abuse problem based CAGE-AID (endorsing two or more\n             items)\n\n          -  History of Bipolar Disorder, Schizophrenia, Schizoaffective Disorder, or any\n             Psychotic Disorder by medical history or self-report.\n\n          -  Presence of non-cardiovascular conditions likely to be fatal within 1 year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The study population for this study will be drawn from cardiac surgery patients at a\n        university-based hospital who will undergo coronary artery bypass graft (CABG) surgery."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01838356", 
            "org_study_id": "MH085740"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Depression", 
            "Vascular depression", 
            "Intracranial atherosclerosis", 
            "Coronary artery disease", 
            "Coronary artery bypass graft", 
            "Cognitive impairment"
        ], 
        "lastchanged_date": "April 23, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Hochang B Lee, MD", 
                    "phone": "203-785-2618"
                }, 
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }, 
                    "name": "Yale University School of Medicine"
                }, 
                "investigator": {
                    "last_name": "Hochang B Lee, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21218"
                    }, 
                    "name": "The Johns Hopkins University"
                }, 
                "status": "Terminated"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Intracranial Atherosclerosis and Predictors of Post-CABG Depression", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pre-surgical intracranial atherosclerosis as measured by transcranial doppler ultrasound relative to depressive symptoms post-surgically as measured by DISH.", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01838356"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Yale University", 
            "investigator_full_name": "Hochang Benjamin Lee", 
            "investigator_title": "Associate Professor of Psychiatry", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Neurocognitive tests are aimed at evaluating memory, processing speed, and global cognition.", 
            "measure": "Examine neurocognitive function relative to post-CABG depression through a series of neurocognitive tests.", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "Yale University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yale University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}